Cargando…
Clinical practice guideline monitoring children and young people with, or at risk of developing autosomal dominant polycystic kidney disease (ADPKD)
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is thought to affect about 1 in 1000 people in the UK. ADPKD causes a progressive decline in kidney function, with kidney failure tending to occur in middle age. Children and young people with ADPKD may not have any symptoms. However they may have...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489289/ https://www.ncbi.nlm.nih.gov/pubmed/31039757 http://dx.doi.org/10.1186/s12882-019-1285-2 |
_version_ | 1783414793912188928 |
---|---|
author | Dudley, Jan Winyard, Paul Marlais, Matko Cuthell, Oliver Harris, Tess Chong, Jiehan Sayer, John Gale, Daniel P. Moore, Lucy Turner, Kay Burrows, Sarah Sandford, Richard |
author_facet | Dudley, Jan Winyard, Paul Marlais, Matko Cuthell, Oliver Harris, Tess Chong, Jiehan Sayer, John Gale, Daniel P. Moore, Lucy Turner, Kay Burrows, Sarah Sandford, Richard |
author_sort | Dudley, Jan |
collection | PubMed |
description | Autosomal Dominant Polycystic Kidney Disease (ADPKD) is thought to affect about 1 in 1000 people in the UK. ADPKD causes a progressive decline in kidney function, with kidney failure tending to occur in middle age. Children and young people with ADPKD may not have any symptoms. However they may have high blood pressure, which may accelerate progression to later stages of chronic kidney disease. There is uncertainty and variation in how health professionals manage children and young people with confirmed or a family history of ADPKD, because of a lack of evidence. For example, health professionals may be unsure about when to test children’s blood pressure and how often to monitor it in the hospital clinic or at the GP. They may have different approaches in recommending scanning or genetic testing for ADPKD in childhood, with some recommending waiting until the young person is mature enough to make this decision his or herself. This guideline is intended to help families affected by ADPKD by making sure that: health professionals with specialist knowledge in ADPKD offer you information on inheritance and potential benefits and harms of testing for ADPKD. the decision to test and the method of testing for ADPKD in children and young people is shared between you or your family and the health professionals; blood pressure assessment is undertaken regularly in children and young people at risk of developing ADPKD; |
format | Online Article Text |
id | pubmed-6489289 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-64892892019-06-05 Clinical practice guideline monitoring children and young people with, or at risk of developing autosomal dominant polycystic kidney disease (ADPKD) Dudley, Jan Winyard, Paul Marlais, Matko Cuthell, Oliver Harris, Tess Chong, Jiehan Sayer, John Gale, Daniel P. Moore, Lucy Turner, Kay Burrows, Sarah Sandford, Richard BMC Nephrol Guidelines Autosomal Dominant Polycystic Kidney Disease (ADPKD) is thought to affect about 1 in 1000 people in the UK. ADPKD causes a progressive decline in kidney function, with kidney failure tending to occur in middle age. Children and young people with ADPKD may not have any symptoms. However they may have high blood pressure, which may accelerate progression to later stages of chronic kidney disease. There is uncertainty and variation in how health professionals manage children and young people with confirmed or a family history of ADPKD, because of a lack of evidence. For example, health professionals may be unsure about when to test children’s blood pressure and how often to monitor it in the hospital clinic or at the GP. They may have different approaches in recommending scanning or genetic testing for ADPKD in childhood, with some recommending waiting until the young person is mature enough to make this decision his or herself. This guideline is intended to help families affected by ADPKD by making sure that: health professionals with specialist knowledge in ADPKD offer you information on inheritance and potential benefits and harms of testing for ADPKD. the decision to test and the method of testing for ADPKD in children and young people is shared between you or your family and the health professionals; blood pressure assessment is undertaken regularly in children and young people at risk of developing ADPKD; BioMed Central 2019-04-30 /pmc/articles/PMC6489289/ /pubmed/31039757 http://dx.doi.org/10.1186/s12882-019-1285-2 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Guidelines Dudley, Jan Winyard, Paul Marlais, Matko Cuthell, Oliver Harris, Tess Chong, Jiehan Sayer, John Gale, Daniel P. Moore, Lucy Turner, Kay Burrows, Sarah Sandford, Richard Clinical practice guideline monitoring children and young people with, or at risk of developing autosomal dominant polycystic kidney disease (ADPKD) |
title | Clinical practice guideline monitoring children and young people with, or at risk of developing autosomal dominant polycystic kidney disease (ADPKD) |
title_full | Clinical practice guideline monitoring children and young people with, or at risk of developing autosomal dominant polycystic kidney disease (ADPKD) |
title_fullStr | Clinical practice guideline monitoring children and young people with, or at risk of developing autosomal dominant polycystic kidney disease (ADPKD) |
title_full_unstemmed | Clinical practice guideline monitoring children and young people with, or at risk of developing autosomal dominant polycystic kidney disease (ADPKD) |
title_short | Clinical practice guideline monitoring children and young people with, or at risk of developing autosomal dominant polycystic kidney disease (ADPKD) |
title_sort | clinical practice guideline monitoring children and young people with, or at risk of developing autosomal dominant polycystic kidney disease (adpkd) |
topic | Guidelines |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489289/ https://www.ncbi.nlm.nih.gov/pubmed/31039757 http://dx.doi.org/10.1186/s12882-019-1285-2 |
work_keys_str_mv | AT dudleyjan clinicalpracticeguidelinemonitoringchildrenandyoungpeoplewithoratriskofdevelopingautosomaldominantpolycystickidneydiseaseadpkd AT winyardpaul clinicalpracticeguidelinemonitoringchildrenandyoungpeoplewithoratriskofdevelopingautosomaldominantpolycystickidneydiseaseadpkd AT marlaismatko clinicalpracticeguidelinemonitoringchildrenandyoungpeoplewithoratriskofdevelopingautosomaldominantpolycystickidneydiseaseadpkd AT cuthelloliver clinicalpracticeguidelinemonitoringchildrenandyoungpeoplewithoratriskofdevelopingautosomaldominantpolycystickidneydiseaseadpkd AT harristess clinicalpracticeguidelinemonitoringchildrenandyoungpeoplewithoratriskofdevelopingautosomaldominantpolycystickidneydiseaseadpkd AT chongjiehan clinicalpracticeguidelinemonitoringchildrenandyoungpeoplewithoratriskofdevelopingautosomaldominantpolycystickidneydiseaseadpkd AT sayerjohn clinicalpracticeguidelinemonitoringchildrenandyoungpeoplewithoratriskofdevelopingautosomaldominantpolycystickidneydiseaseadpkd AT galedanielp clinicalpracticeguidelinemonitoringchildrenandyoungpeoplewithoratriskofdevelopingautosomaldominantpolycystickidneydiseaseadpkd AT moorelucy clinicalpracticeguidelinemonitoringchildrenandyoungpeoplewithoratriskofdevelopingautosomaldominantpolycystickidneydiseaseadpkd AT turnerkay clinicalpracticeguidelinemonitoringchildrenandyoungpeoplewithoratriskofdevelopingautosomaldominantpolycystickidneydiseaseadpkd AT burrowssarah clinicalpracticeguidelinemonitoringchildrenandyoungpeoplewithoratriskofdevelopingautosomaldominantpolycystickidneydiseaseadpkd AT sandfordrichard clinicalpracticeguidelinemonitoringchildrenandyoungpeoplewithoratriskofdevelopingautosomaldominantpolycystickidneydiseaseadpkd |